Literature DB >> 7953039

Family-based intervention for schizophrenic patients in China. A randomised controlled trial.

W Xiong1, M R Phillips, X Hu, R Wang, Q Dai, J Kleinman, A Kleinman.   

Abstract

BACKGROUND: We developed and evaluated a comprehensive, ongoing intervention for families of schizophrenic patients appropriate for China's complex family relationships and unique social environment.
METHOD: Sixty-three DSM-III-R schizophrenic patients living with family members were enrolled when admitted to hospital and randomly assigned to receive standard care or a family-based intervention that included monthly 45-minute counselling sessions focused on the management of social and occupational problems, medication management, family education, family group meetings, and crisis intervention.
RESULTS: At 6, 12, and 18-month follow-ups by blind evaluators, the proportion of subjects rehospitalised was lower, the duration of rehospitalisation was shorter, and the duration of employment was longer in the experimental group than in the control group; these differences were statistically significant at the 12 and 18-month follow-ups and were not explained by differences in drug compliance. Family intervention was associated with significantly lower levels of family burden.
CONCLUSIONS: This intervention is less costly than standard treatment, is suitable for urban families of schizophrenic patients in China and feasible given the constraints of the Chinese mental health system.

Entities:  

Mesh:

Year:  1994        PMID: 7953039     DOI: 10.1192/bjp.165.2.239

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  42 in total

1.  Staff training in cognitive-behavioral family intervention in mental illness using the multiple-family group approach: a pilot study.

Authors:  R E Laube; F M Higson
Journal:  Community Ment Health J       Date:  2000-10

2.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

3.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses.

Authors:  Mario Pfammatter; Ulrich Martin Junghan; Hans Dieter Brenner
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

4.  Family interventions for mental disorders: efficacy and effectiveness.

Authors:  Ian R H Falloon
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

5.  HIV/STD stigmatization fears as health-seeking barriers in China.

Authors:  Eli Lieber; Li Li; Zunyou Wu; Mary Jane Rotheram-Borus; Jihui Guan
Journal:  AIDS Behav       Date:  2006-09

Review 6.  State of the science on psychosocial interventions for ethnic minorities.

Authors:  Jeanne Miranda; Guillermo Bernal; Anna Lau; Laura Kohn; Wei-Chin Hwang; Teresa LaFromboise
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 7.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 8.  Family interventions in schizophrenia: Issues of relevance for Asian countries.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2011-12-31

Review 9.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

10.  Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis.

Authors:  Dan Chisholm; Oye Gureje; Sandra Saldivia; Marcelo Villalón Calderón; Rajitha Wickremasinghe; Nalaka Mendis; Jose-Luis Ayuso-Mateos; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.